Literature DB >> 11986272

Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus.

Les P Jones1, Hao-Qiang Zheng, Ruth A Karron, Teresa C T Peret, Cecelia Tsou, Larry J Anderson.   

Abstract

The role of strain differences in respiratory syncytial virus (RSV) disease has not been clearly defined. To investigate the possibility that strain differences contribute to susceptibility to repeat infections, we developed assays to detect antibodies to the two variable regions of the RSV G protein by cloning and expressing the internal variable region at amino acids (aa) 60 to 172 (g1) and the carboxy-terminal variable region at aa 193 to the carboxy terminus (g2) from different genotypes of RSV. The purified proteins were covalently linked to beads with different proportions of red and orange fluorescent dyes and reacted against serum specimens. Antibody reacting against the differently colored beads, and thus against different G polypeptides, was detected by use of flow cytometry and the Luminex system. This assay system detected group- and, to some extent, genotype-specific responses to RSV infection and can be used to investigate the role of strain differences in RSV disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986272      PMCID: PMC119994          DOI: 10.1128/cdli.9.3.633-638.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  40 in total

1.  Multicenter study of strains of respiratory syncytial virus.

Authors:  L J Anderson; R M Hendry; L T Pierik; C Tsou; K McIntosh
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

2.  The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.

Authors:  P R Johnson; M K Spriggs; R A Olmsted; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections.

Authors:  P M Muelenaer; F W Henderson; V G Hemming; E E Walsh; L J Anderson; G A Prince; B R Murphy
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

4.  Epidemic infections caused by respiratory syncytial virus in institutionalized young adults.

Authors:  R Finger; L J Anderson; R C Dicker; B Harrison; R Doan; A Downing; L Corey
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

5.  Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.

Authors:  E J Stott; G Taylor; L A Ball; K Anderson; K K Young; A M King; G W Wertz
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

6.  The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity.

Authors:  C Palomo; B García-Barreno; C Peñas; J A Melero
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

7.  Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus.

Authors:  E Norrby; M A Mufson; H Alexander; R A Houghten; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections.

Authors:  M A Mufson; R B Belshe; C Orvell; E Norrby
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

9.  Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.

Authors:  P R Johnson; R A Olmsted; G A Prince; B R Murphy; D W Alling; E E Walsh; P L Collins
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

10.  Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived.

Authors:  M Connors; P L Collins; C Y Firestone; B R Murphy
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more
  21 in total

1.  Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.

Authors:  Yoshihiko Murata; Seana C Catherman
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

2.  Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants.

Authors:  Nefertiti C dupont; Kehui Wang; Pathik D Wadhwa; Jennifer F Culhane; Edward L Nelson
Journal:  J Reprod Immunol       Date:  2005-08       Impact factor: 4.054

3.  Simultaneous detection of antibodies to five simian viruses in nonhuman primates using recombinant viral protein based multiplex microbead immunoassays.

Authors:  Qi Liao; Huishan Guo; Min Tang; Neal Touzjian; Nicholas W Lerche; Yichen Lu; JoAnn L Yee
Journal:  J Virol Methods       Date:  2011-09-17       Impact factor: 2.014

4.  Nucleotide and predicted amino acid sequence-based analysis of the avian metapneumovirus type C cell attachment glycoprotein gene: phylogenetic analysis and molecular epidemiology of U.S. pneumoviruses.

Authors:  Rene Alvarez; Humphrey M Lwamba; Darrell R Kapczynski; M Kariuki Njenga; Bruce S Seal
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Analysis of liquid bead microarray antibody assay data for epidemiologic studies of pathogen-cancer associations.

Authors:  Danny V Colombara; James P Hughes; Andrea N Burnett-Hartman; Stephen E Hawes; Denise A Galloway; Stephen M Schwartz; Roberd M Bostick; John D Potter; Lisa E Manhart
Journal:  J Immunol Methods       Date:  2015-06-11       Impact factor: 2.303

6.  Determination of serum IgG antibodies to Bacillus anthracis protective antigen in environmental sampling workers using a fluorescent covalent microsphere immunoassay.

Authors:  R E Biagini; D L Sammons; J P Smith; E H Page; J E Snawder; C A F Striley; B A MacKenzie
Journal:  Occup Environ Med       Date:  2004-08       Impact factor: 4.402

7.  Multianalyte tests for the early detection of cancer: speedbumps and barriers.

Authors:  Michael A Tainsky; Madhumita Chatterjee; Nancy K Levin; Sorin Draghici; Judith Abrams
Journal:  Biomark Insights       Date:  2007-07-10

8.  Influence of respiratory syncytial virus strain differences on pathogenesis and immunity.

Authors:  José A Melero; Martin L Moore
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

9.  Naturally occurring IgG antibody levels to the Staphylococcus aureus protein IsdB in humans.

Authors:  Julie K Zorman; Mark Esser; Michael Raedler; Barry N Kreiswirth; Dlawer A A Ala'Aldeen; Nicholas Kartsonis; Steven S Smugar; Annaliesa S Anderson; Tessie McNeely; Jean Marie Arduino
Journal:  Hum Vaccin Immunother       Date:  2013-06-18       Impact factor: 3.452

10.  Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.

Authors:  Wenliang Zhang; Youngjoo Choi; Lia M Haynes; Jennifer L Harcourt; Larry J Anderson; Les P Jones; Ralph A Tripp
Journal:  J Virol       Date:  2009-10-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.